Additionally, the combination of nivolumab and BGB324 prolongs the survival period of mice with GBM [23], and the combination of TP0903 and WEE1 inhibitor can overcome the resistance of SCLC to WEE1 inhibitor [63]. The gene discussed is WEE1; the disease is glioblastoma.